We are live on ! Find out more
CRC

Catawba River Capital Portfolio holdings

AUM $223M
1-Year Est. Return 24.34%
This Fund
S&P 500
This Quarter Est. Return
+12.98%
1 Year Est. Return
+24.34%
3 Year Est. Return
+89.48%
5 Year Est. Return
+91.16%
10 Year Est. Return
–
AUM
$223M
AUM Growth
+$15.5M
Cap. Flow
+$3.91M
Cap. Flow %
1.75%
Top 10 Hldgs %
71.94%
Holding
26
New
2
Increased
15
Reduced
6
Closed
2
Avg Time Held
9.7 quarters
Top 10 Avg Time Held
9.3 quarters
Top 20 Avg Time Held
9.9 quarters

Sector Composition

Rank Sector Weight
1 Industrials 50.79%
2 Miscellaneous 21.51%
3 Materials 11.71%
4 Consumer Discretionary 5.56%
5 Technology 3.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ROP icon
26
Roper Technologies
ROP
$35B
– –
-15,669
Closed -$5.58M –

Similar funds

Catawba River Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Catawba River Capital held 26 positions worth $223M, up 7.4% from $208M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Catawba River Capital's Q2 2026 filing shows 2 new, 15 increased, 6 reduced and 2 closed positions. Its largest new stake was Novanta: 52,245 shares worth $8.48M. The largest sale was Regeneron Pharmaceuticals, an estimated $13M.

By sector, the portfolio is most concentrated in Industrials at 51% of assets, up from 46% a quarter earlier, followed by Miscellaneous and Materials.

  • Catawba River Capital's largest Q2 2026 buy was Novanta: 52,245 shares worth $8.48M.
  • Catawba River Capital added most to Cadre Holdings in Q2 2026, an estimated $10.2M increase.
  • Catawba River Capital's biggest Q2 2026 reduction was Full House Resorts, cutting an estimated $763K.
  • Catawba River Capital fully exited Regeneron Pharmaceuticals in Q2 2026, selling an estimated $13M.
  • Catawba River Capital's ten largest holdings make up 72% of its $223M portfolio in Q2 2026.
  • Catawba River Capital opened 2 new positions and closed 2 in Q2 2026.
  • Catawba River Capital's portfolio value rose 7.4% quarter-over-quarter to $223M.

Based on Catawba River Capital's 13F filing for Q2 2026, filed 22 Jul 2026.